Healthcare - Biotechnology - NYSE - US
$ 15.7
-0.444 %
$ 1.44 B
Market Cap
-4.92
P/E
Price Target
Average
104.62%
Revenue Forecast
Estimate
52.81%
EBIT
Estimate
--9.68%
Net Income
Estimate
29.44%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Arcus Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for RCUS of $32.1 , with forecasts ranging from a low of $20 to a high of $46 .
RCUS Lowest Price Target
Wall Street Target
20 USD
27.39%
RCUS Average Price Target
Wall Street Target
32.1 USD
104.62%
RCUS Highest Price Target
Wall Street Target
46 USD
192.99%
REVENUE FORECAST
Revenue Forecast Chart RCUS
EBIT FORECAST
EBIT Forecast Chart RCUS
NET INCOME FORECAST
Net Income Chart RCUS